News
Discover the challenges surrounding AMED's merger with UnitedHealth, including regulatory concerns, imbalance in terms, and ...
37m
Stocktwits on MSNBaxter Downgraded By Stifel On Soft Q2, Guidance Cut — But Retail Eyes A ReboundStifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results